Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects].

Nihon rinsho. Japanese journal of clinical medicine - 1 Jul 1994

Fukui S, Tohyama H, Iwabuchi S

Abstract excerpt

In order to prevent the progression to chronicity of acute hepatitis C, we treated 22 patients with natural human alpha or beta interferon (IFN) in varying doses (3-6 megaunit) daily, for 4 weeks everyday or TIW for 8 weeks. 14 (63.6%) of the 22 patients was cured with IFN therapy. According to the level of serum HCV RNA, 5 (83%) of the 6 patients with more than 10(5) copies/ml were progressed to chronicity,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Adolescent
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C

Share to Interferon-alpha

Share to RNA, Viral

Source

Identifiers

PMID: 7521429

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Interferon therapy for acute hepatitis C; changes in serum markers associated with HCV and clinical effects].PMID 7521429Read ↗

[Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].Semantic proximity Read ↗

[Titration and genotyping of hepatitis C virus RNA in chronic hepatitis C patients treated with interferon].Semantic proximity Read ↗

[Efficacy of interferon alpha with ribavirin for treatment of chronic Hepatitis C].Semantic proximity Read ↗

[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].Semantic proximity Read ↗

Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.Semantic proximity Read ↗

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.Semantic proximity Read ↗

Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.Semantic proximity Read ↗

Alpha interferon treatment in chronic hepatitis C.Semantic proximity Read ↗

[Proliferation mechanism of hepatitis C virus and effectiveness of interferon therapy].Semantic proximity Read ↗

Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.Semantic proximity Read ↗

High-dose natural interferon-alpha therapy for chronic hepatitis C with a high viral load: predictors of efficacy. The Aomori, Akita and Iwate Areas Viral Hepatitis Research Group.Semantic proximity Read ↗

[Examination in clinical course of HCV in interferon treatment].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.